SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

Palo Alto Networks: Hamas-linked hackers launch stealth espionage push across Arab governments

Omri Casspi raises $100 million follow-on fund to double down on Israeli tech

BlackRock in talks for major investment in creative-tech firm Artlist

Buzz

Most popular

Daily

Weekly

1

Breaking down the resurgence of M&As in times of economic uncertainty

2

Quantum Art raises $100 million Series A to scale full-stack quantum systems

3

Dell in talks to acquire AI data-infrastructure startup Dataloop

4

A two-year-old Israeli unicorn is quietly stress-testing Amazon’s AI future

5

After over $390 million in funding, Believer Meats abruptly shuts down

UroGen

5 stories about UroGen

אריה בלדגרין דוקטור מנכ"ל ו ממייסדי קייט פארמה

”Exits are not a Strategy. I Never put up a ‘For Sale’ Sign”

23.05.20|Sophie Shulman and Golan Hazani

Arie Belldegrun, chairman of UroGen Pharma, talks about catching Covid-19 and gaining FDA approval in the midst of a global pandemic

Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen

The two companies will collaborate on the research of a “therapeutic area of mutual interest”

Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq

24.01.19|Lilach Baumer

Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18|Amir Rosenbaum

Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections

Allergan Partners with Urine Incontinence Treatment Company

08.11.17|Lilach Baumer

Allergan is conducting clinical trials for a Botox-based bladder treatment, using a sustained release gel developed by Israel-based UroGen